Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.

Molecular biology reports - 1 Sept 2022

de Souza Milene Roldão, de Souza Marilesia Ferreira, de Nóbrega Monyse, Cilião Heloísa Lizotti, Dos Reis Mariana Bisarro, Fuganti Paulo Emílio, Cólus Ilce Mara de Syllos

Abstract excerpt

BACKGROUND: There is an ongoing search for molecular markers that are specific, sensitive, and able to predict the stage of prostate cancer (PCa), which is the second most prevalent type of cancer in men worldwide. This study examined whether different single nucleotide polymorphisms (SNPs) were reliable markers of susceptibility to and prognosis of PCa in a sample of Brazilian patients. METHODS AND RESULTS: DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Transcription Factors
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Caspase 3

Share to Caspase 9

Share to Genes, bcl-2

Share to Homeodomain Proteins

Share to Prostatic Neoplasms

Share to Proto-Oncogene Proteins c-bcl-2

Source

Identifiers

PMID: 35708863
DOI: 10.1007/s11033-022-07654-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.PMID 35708863Read ↗

Association among polymorphisms in the apoptosis-related NKX3-1, caspase-3, caspase-9, and BCL-2 genes and prostate cancer susceptibility from 9,706 cases and 12,567 controlsSemantic proximity Read ↗

Association Aamong Ppolymorphisms in the Aapoptosis-Rrelated NKX3-1, Caspase-3, Caspase-9, and BCL-2 Genes and Prostate Cancer Susceptibility From 9706 Cases and 12,567 Controls.Semantic proximity Read ↗

Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.Semantic proximity Read ↗

Genetic factors influencing prostate cancer risk in Norwegian men.Semantic proximity Read ↗

BCL2 genotypes and prostate cancer survival.Semantic proximity Read ↗

Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain).Semantic proximity Read ↗

Association between three genetic variants in kallikrein 3 and prostate cancer riskSemantic proximity Read ↗

Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.Semantic proximity Read ↗

Associations of the Expression Levels and Risk Variants of CDKN2B-AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer.Semantic proximity Read ↗

Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.Semantic proximity Read ↗

An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.